CEEOG publications Cheang MCU, Bliss JM, Viale G, Speirs V, Palmieri C, Shaaban A, Lønning PE, Morden J, Porta N, Jassem J, van De Velde CJ, Rasmussen BB, Verhoeven D, Bartlett JMS, Coombes RC; PathIES Sub-Committee. Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIES. Breast Cancer Res Treat. 2018 Feb;168(1):169-178. von Minckwitz G, Procter M, de Azambuja E, Zardavas D, Benyunes M, Viale G, Suter T, Arahmani A, Rouchet N, Clark E, Knott A, Lang I, Levy C, Yardley DA, Bines J, Gelber RD, Piccart M, Baselga...

CEEOG conference communication Wu NC, Wong W, Ho KE, Chu VC, Rizo A, Davonport S, Kelly D, Makar R, Jassem J, Duchnowska R, Biernat W, Radecka B, Fujita T, Klein JL, Stonecypher M, Otha S, Juhl H, Weidler JM, Bates M, Press MF. High concordance of ER, PR, HER2 and Ki67 by central IHC and FISH with MRNA measurements by GeneXpert breast cancer stratifier assay [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P1-03-03.

 Conference abstracts S. Kerpel-Fronius, Z. Mechl, J. Csetenyi, T. Nagykalnai, F. Gyergyay, J. Jassem et al.: Pharmacocinetic and response rate of 5-Fluorouracil given in daily 4h infusion combined with cisplatin in head and neck cancer. Phase I-II study. Proc. Annual ASCO meeting, 1988, 150. K. Kolaric, S. Eckhardt, J. Jassem, E. Kanitz, A. Tamas, C. Intini, Z. Schoket, M. Pawlicki. Phase II randomized study of high-dose epirubicin combined with either cyclophosphamide or cisplatin in small cell lung cancer. Proc 16 Int Congress of Chemother,...